BioMarin Pharmaceutical Inc.

BioMarin Names Cara Bauer Chief People Officer, Succeeding Wireman

BioMarin Names Cara Bauer Chief People Officer, Succeeding Wireman

San Rafael, Calif. – October 06, 2026 -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) appointed Cara Bauer, Ph.D., as Executive Vice President, Chief People Officer, effective Oct. 5, 2026, succeeding Amy Wireman, who is retiring after nearly 14 years at the company.

Bauer arrives with 25 years of HR leadership across biotech and technology

Bauer joins BioMarin from Kyverna Therapeutics, Inc., where she served as Chief Human Resources Officer starting October 2024. She previously held the role of global head of human resources at Kite, a Gilead company, and led HR for the entertainment division at Riot Games. Earlier in her career she held HR leadership positions at Netflix, Amgen and Novo Nordisk.

BioMarin Adds Bristol Myers Squibb Research Chief Robert Plenge to Board

BioMarin Adds Bristol Myers Squibb Research Chief Robert Plenge to Board

San Rafael, Calif. – September 18, 2026 -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has appointed Robert Plenge, M.D., Ph.D., to its Board of Directors, effective September 18, 2026.

Plenge brings nine-site global research oversight from Bristol Myers Squibb

Dr. Plenge currently serves as Executive Vice President, Chief Research Officer and Head of Research at Bristol Myers Squibb, directing scientific operations across nine research sites worldwide. He joined the company in November 2019 through its acquisition of Celgene Corp., where he had led the immunology and inflammation portfolio in research and early development.